SCHEMBL19732290

SCHEMBL19732290

C=C1CCCN1NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761439 0.70
SCHEMBL266971 0.65
SCHEMBL2667175 0.63
SCHEMBL6010064 0.63
SCHEMBL21389462 0.63 CYP1A2 (0.32)
SCHEMBL15491220 0.63 CARM1 (0.43)
SCHEMBL13764703 0.62
SCHEMBL14625026 0.61 NOTUM (0.50)
SCHEMBL783007 0.60
SCHEMBL2754730 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470409-B1 BENZOTRIAZOLE-DERIVED ALPHA AND BETA-UNSATURATED AMIDE COMPOUND USED AS TGF-BETA RI INHIBITOR GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2020-02-12 EP disclosed
WO-2017215506-A1 BENZOTRIAZOLE-DERIVED Α AND Β UNSATURATED AMIDE COMPOUND USED AS TGF-ΒR1 INHIBITOR 南京明德新药研发股份有限公司 2017-12-21 WO disclosed